Raytech Holding Limited Ordinary Shares (RAY) Stock Competitors & Peer Comparison

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, PG has a market cap of 341.2B. Regarding current trading prices, RAY is priced at $3.07, while PG trades at $146.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas PG's P/E ratio is 21.42. In terms of profitability, RAY's ROE is +0.09%, compared to PG's ROE of +0.31%. Regarding short-term risk, RAY is more volatile compared to PG. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check PG's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, UL has a market cap of 122.8B. Regarding current trading prices, RAY is priced at $3.07, while UL trades at $56.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas UL's P/E ratio is 18.78. In terms of profitability, RAY's ROE is +0.09%, compared to UL's ROE of +0.36%. Regarding short-term risk, RAY is more volatile compared to UL. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check UL's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, CL has a market cap of 70.9B. Regarding current trading prices, RAY is priced at $3.07, while CL trades at $88.58.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas CL's P/E ratio is 34.32. In terms of profitability, RAY's ROE is +0.09%, compared to CL's ROE of +4.75%. Regarding short-term risk, RAY is more volatile compared to CL. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check CL's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, KVUE has a market cap of 34B. Regarding current trading prices, RAY is priced at $3.07, while KVUE trades at $17.71.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas KVUE's P/E ratio is 21.09. In terms of profitability, RAY's ROE is +0.09%, compared to KVUE's ROE of +0.15%. Regarding short-term risk, RAY is less volatile compared to KVUE. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check KVUE's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, KMB has a market cap of 32.9B. Regarding current trading prices, RAY is priced at $3.07, while KMB trades at $99.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas KMB's P/E ratio is 19.16. In terms of profitability, RAY's ROE is +0.09%, compared to KMB's ROE of +1.44%. Regarding short-term risk, RAY is less volatile compared to KMB. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check KMB's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, EL has a market cap of 30.2B. Regarding current trading prices, RAY is priced at $3.07, while EL trades at $83.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas EL's P/E ratio is -119.26. In terms of profitability, RAY's ROE is +0.09%, compared to EL's ROE of -0.06%. Regarding short-term risk, RAY is more volatile compared to EL. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check EL's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, CHD has a market cap of 22.9B. Regarding current trading prices, RAY is priced at $3.07, while CHD trades at $96.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas CHD's P/E ratio is 31.83. In terms of profitability, RAY's ROE is +0.09%, compared to CHD's ROE of +0.17%. Regarding short-term risk, RAY is more volatile compared to CHD. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check CHD's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, SGI has a market cap of 14.3B. Regarding current trading prices, RAY is priced at $3.07, while SGI trades at $68.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas SGI's P/E ratio is 27.19. In terms of profitability, RAY's ROE is +0.09%, compared to SGI's ROE of +0.17%. Regarding short-term risk, RAY is more volatile compared to SGI. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check SGI's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, CLX has a market cap of 11.4B. Regarding current trading prices, RAY is priced at $3.07, while CLX trades at $94.14.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas CLX's P/E ratio is 15.31. In terms of profitability, RAY's ROE is +0.09%, compared to CLX's ROE of +28.26%. Regarding short-term risk, RAY is more volatile compared to CLX. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check CLX's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, NTCO has a market cap of 4.6B. Regarding current trading prices, RAY is priced at $3.07, while NTCO trades at $6.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas NTCO's P/E ratio is -11.37. In terms of profitability, RAY's ROE is +0.09%, compared to NTCO's ROE of -0.15%. Regarding short-term risk, RAY is more volatile compared to NTCO. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check NTCO's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, ELF has a market cap of 2.9B. Regarding current trading prices, RAY is priced at $3.07, while ELF trades at $49.57.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas ELF's P/E ratio is 112.66. In terms of profitability, RAY's ROE is +0.09%, compared to ELF's ROE of +0.05%. Regarding short-term risk, RAY is less volatile compared to ELF. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check ELF's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, IPAR has a market cap of 2.9B. Regarding current trading prices, RAY is priced at $3.07, while IPAR trades at $91.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas IPAR's P/E ratio is 17.32. In terms of profitability, RAY's ROE is +0.09%, compared to IPAR's ROE of +0.19%. Regarding short-term risk, RAY is more volatile compared to IPAR. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check IPAR's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, SPB has a market cap of 1.9B. Regarding current trading prices, RAY is priced at $3.07, while SPB trades at $81.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas SPB's P/E ratio is 15.94. In terms of profitability, RAY's ROE is +0.09%, compared to SPB's ROE of +0.07%. Regarding short-term risk, RAY is more volatile compared to SPB. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check SPB's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, COTY has a market cap of 1.7B. Regarding current trading prices, RAY is priced at $3.07, while COTY trades at $1.96.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas COTY's P/E ratio is -3.17. In terms of profitability, RAY's ROE is +0.09%, compared to COTY's ROE of -0.15%. Regarding short-term risk, RAY is less volatile compared to COTY. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check COTY's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, NWL has a market cap of 1.6B. Regarding current trading prices, RAY is priced at $3.07, while NWL trades at $3.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas NWL's P/E ratio is -5.55. In terms of profitability, RAY's ROE is +0.09%, compared to NWL's ROE of -0.11%. Regarding short-term risk, RAY is less volatile compared to NWL. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check NWL's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, EPC has a market cap of 916.6M. Regarding current trading prices, RAY is priced at $3.07, while EPC trades at $19.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas EPC's P/E ratio is -86.48. In terms of profitability, RAY's ROE is +0.09%, compared to EPC's ROE of -0.05%. Regarding short-term risk, RAY is more volatile compared to EPC. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check EPC's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, HELE has a market cap of 566.1M. Regarding current trading prices, RAY is priced at $3.07, while HELE trades at $24.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas HELE's P/E ratio is -0.62. In terms of profitability, RAY's ROE is +0.09%, compared to HELE's ROE of -0.95%. Regarding short-term risk, RAY is more volatile compared to HELE. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check HELE's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, EWCZ has a market cap of 319.1M. Regarding current trading prices, RAY is priced at $3.07, while EWCZ trades at $5.82.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas EWCZ's P/E ratio is 29.10. In terms of profitability, RAY's ROE is +0.09%, compared to EWCZ's ROE of +0.10%. Regarding short-term risk, RAY is more volatile compared to EWCZ. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check EWCZ's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, NUS has a market cap of 261.2M. Regarding current trading prices, RAY is priced at $3.07, while NUS trades at $5.37.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas NUS's P/E ratio is 4.98. In terms of profitability, RAY's ROE is +0.09%, compared to NUS's ROE of +0.07%. Regarding short-term risk, RAY is more volatile compared to NUS. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check NUS's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, PTNM has a market cap of 207.9M. Regarding current trading prices, RAY is priced at $3.07, while PTNM trades at $10.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas PTNM's P/E ratio is 346.33. In terms of profitability, RAY's ROE is +0.09%, compared to PTNM's ROE of -0.05%. Regarding short-term risk, RAY is more volatile compared to PTNM. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check PTNM's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, ACU has a market cap of 167.7M. Regarding current trading prices, RAY is priced at $3.07, while ACU trades at $43.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas ACU's P/E ratio is 18.97. In terms of profitability, RAY's ROE is +0.09%, compared to ACU's ROE of +0.08%. Regarding short-term risk, RAY is more volatile compared to ACU. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check ACU's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, SLSN has a market cap of 92.5M. Regarding current trading prices, RAY is priced at $3.07, while SLSN trades at $1.31.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas SLSN's P/E ratio is 131.00. In terms of profitability, RAY's ROE is +0.09%, compared to SLSN's ROE of +0.05%. Regarding short-term risk, RAY is less volatile compared to SLSN. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check SLSN's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, SKIN has a market cap of 78.7M. Regarding current trading prices, RAY is priced at $3.07, while SKIN trades at $0.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas SKIN's P/E ratio is -4.67. In terms of profitability, RAY's ROE is +0.09%, compared to SKIN's ROE of -0.09%. Regarding short-term risk, RAY is less volatile compared to SKIN. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check SKIN's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, GROV has a market cap of 48.8M. Regarding current trading prices, RAY is priced at $3.07, while GROV trades at $1.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas GROV's P/E ratio is -4.30. In terms of profitability, RAY's ROE is +0.09%, compared to GROV's ROE of -1.06%. Regarding short-term risk, RAY is less volatile compared to GROV. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check GROV's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, AXIL has a market cap of 47.3M. Regarding current trading prices, RAY is priced at $3.07, while AXIL trades at $6.85.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas AXIL's P/E ratio is 57.83. In terms of profitability, RAY's ROE is +0.09%, compared to AXIL's ROE of +0.09%. Regarding short-term risk, RAY is less volatile compared to AXIL. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check AXIL's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, UG has a market cap of 32.1M. Regarding current trading prices, RAY is priced at $3.07, while UG trades at $7.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas UG's P/E ratio is 13.44. In terms of profitability, RAY's ROE is +0.09%, compared to UG's ROE of +0.21%. Regarding short-term risk, RAY is less volatile compared to UG. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check UG's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, MTEX has a market cap of 11M. Regarding current trading prices, RAY is priced at $3.07, while MTEX trades at $5.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas MTEX's P/E ratio is -0.85. In terms of profitability, RAY's ROE is +0.09%, compared to MTEX's ROE of -23.83%. Regarding short-term risk, RAY is more volatile compared to MTEX. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check MTEX's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, PHH has a market cap of 10M. Regarding current trading prices, RAY is priced at $3.07, while PHH trades at $0.39.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas PHH's P/E ratio is -0.53. In terms of profitability, RAY's ROE is +0.09%, compared to PHH's ROE of +0.38%. Regarding short-term risk, RAY is less volatile compared to PHH. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check PHH's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, BRSH has a market cap of 8.7M. Regarding current trading prices, RAY is priced at $3.07, while BRSH trades at $0.09.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas BRSH's P/E ratio is -0.01. In terms of profitability, RAY's ROE is +0.09%, compared to BRSH's ROE of +1.19%. Regarding short-term risk, RAY is less volatile compared to BRSH. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check BRSH's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, DSY has a market cap of 8.4M. Regarding current trading prices, RAY is priced at $3.07, while DSY trades at $1.77.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas DSY's P/E ratio is -0.20. In terms of profitability, RAY's ROE is +0.09%, compared to DSY's ROE of +14.77%. Regarding short-term risk, RAY is less volatile compared to DSY. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check DSY's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, TANH has a market cap of 2.6M. Regarding current trading prices, RAY is priced at $3.07, while TANH trades at $0.42.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas TANH's P/E ratio is -0.03. In terms of profitability, RAY's ROE is +0.09%, compared to TANH's ROE of -0.25%. Regarding short-term risk, RAY is less volatile compared to TANH. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check TANH's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, DSYWW has a market cap of 905.7K. Regarding current trading prices, RAY is priced at $3.07, while DSYWW trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas DSYWW's P/E ratio is N/A. In terms of profitability, RAY's ROE is +0.09%, compared to DSYWW's ROE of +14.77%. Regarding short-term risk, RAY is less volatile compared to DSYWW. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check DSYWW's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, TKLF has a market cap of 836K. Regarding current trading prices, RAY is priced at $3.07, while TKLF trades at $2.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas TKLF's P/E ratio is 1.80. In terms of profitability, RAY's ROE is +0.09%, compared to TKLF's ROE of +0.17%. Regarding short-term risk, RAY is less volatile compared to TKLF. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check TKLF's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, BRSHW has a market cap of 6.1K. Regarding current trading prices, RAY is priced at $3.07, while BRSHW trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas BRSHW's P/E ratio is N/A. In terms of profitability, RAY's ROE is +0.09%, compared to BRSHW's ROE of +1.19%. Regarding short-term risk, RAY is less volatile compared to BRSHW. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check BRSHW's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, SUMR has a market cap of 0. Regarding current trading prices, RAY is priced at $3.07, while SUMR trades at $11.99.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas SUMR's P/E ratio is -3.66. In terms of profitability, RAY's ROE is +0.09%, compared to SUMR's ROE of -0.75%. Regarding short-term risk, RAY is more volatile compared to SUMR. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check SUMR's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, GROV-WT has a market cap of 0. Regarding current trading prices, RAY is priced at $3.07, while GROV-WT trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas GROV-WT's P/E ratio is N/A. In terms of profitability, RAY's ROE is +0.09%, compared to GROV-WT's ROE of -1.06%. Regarding short-term risk, RAY is more volatile compared to GROV-WT. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check GROV-WT's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, RDEN has a market cap of 0. Regarding current trading prices, RAY is priced at $3.07, while RDEN trades at $13.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas RDEN's P/E ratio is N/A. In terms of profitability, RAY's ROE is +0.09%, compared to RDEN's ROE of -0.77%. Regarding short-term risk, RAY is more volatile compared to RDEN. This indicates potentially higher risk in terms of short-term price fluctuations for RAY.Check RDEN's competition here

RAY plays a significant role within the Consumer Defensive sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, RAY stands at 9.1M. In comparison, REV has a market cap of 0. Regarding current trading prices, RAY is priced at $3.07, while REV trades at $3.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

RAY currently has a P/E ratio of 4.15, whereas REV's P/E ratio is -1.19. In terms of profitability, RAY's ROE is +0.09%, compared to REV's ROE of +0.89%. Regarding short-term risk, RAY is less volatile compared to REV. This indicates potentially lower risk in terms of short-term price fluctuations for RAY.Check REV's competition here